Table 2.
No. incident type 2 diabetes cases | Median (range), Lp(a), mg/dL | HR (95% CI) Model 1 | P value | HR (95% CI) Model 2 | P value | HR (95% CI) Model 3 | P value | |
---|---|---|---|---|---|---|---|---|
Quintile | ||||||||
1 | 20 | 2.3 (0.8–3.6) | 1.36 (0.74, 2.48) | 0.326 | 1.35 (0.73, 2.49) | 0.336 | 1.37 (0.74, 2.53) | 0.311 |
2 | 26 | 5.1 (3.7–6.6) | 1.90 (1.04, 3.45) | 0.036 | 2.15 (1.18, 3.93) | 0.013 | 2.24 (1.22, 4.10) | 0.009 |
3 | 17 | 8.8 (6.7–12.3) | 1.42 (0.76, 2.66) | 0.269 | 1.34 (0.71, 2.51) | 0.365 | 1.43 (0.75, 2.71) | 0.276 |
4 | 18 | 17.5 (12.5–26.9) | 1.05 (0.53, 2.08) | 0.896 | 1.02 (0.51, 2.03) | 0.961 | 1.01 (0.51, 2.01) | 0.981 |
5 | 13 | 51.9 (27.1–316.2) | [Reference] | [Reference] | [Reference] | |||
Per SD lower log Lp(a) | 1.10 (0.93, 1.29) | 0.253 | 1.12 (0.95, 1.32) | 0.176 | 1.12 (0.95, 1.32) | 0.171 |
Model 1 was adjusted for age and sex. Model 2 was additionally adjusted for alcohol consumption, BMI, smoking, SES and physical activity. Model 3 was adjusted for the same factors as Models 1 and 2 plus systolic blood pressure, HDL-C, log hsCRP and waist–hip ratio
Usual Lp(a) concentration are predicted long-term average levels of Lp(a) estimated by regressing the log-transformed Lp(a) values measured at the 5-year follow-up on the log-transformed Lp(a) baseline values
CI confidence intervals, BMI body mass index, HDL-C high density lipoprotein cholesterol, HR hazard ratio, hsCRP high sensitivity c-reactive protein, Lp(a) lipoprotein(a), SD standard deviation, SES socioeconomic status